Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response

Cancer Cell

Volumn 7, Issue 2, 2005, Pages 167-178

  Wei, Xiaolong ^a   Xu, Hai ^a   Kufe, Donald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MUCIN 1; ONCOPROTEIN; PROTEIN BAX; PROTEIN P21; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CHROMATIN; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; DNA RESPONSIVE ELEMENT; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRECIPITATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; STRESS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 13844262819     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.01.008     Document Type: Article

References (77)

1. M. Asada, T. Yamada, H. Ichijo, D. Delia, K. Miyazono, K. Fukumuro, and S. Mizutani Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation EMBO J. 18 1999 1223 1234
2. N.A. Barlev, L. Liu, N.H. Chehab, K. Mansfield, K.G. Harris, T.D. Halazonetis, and S.L. Berger Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases Mol. Cell 8 2001 1243 1254
3. G. Blander, J. Kipnis, J.F. Leal, C.E. Yu, G.D. Schellenberg, and M. Oren Physical and functional interaction between p53 and the Werner's syndrome protein J. Biol. Chem. 274 1999 29463 29469
4. F. Bunz, A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, J.P. Brown, J.M. Sedivy, K.W. Kinzler, and B. Vogelstein Requirement for p53 and p21 to sustain G2 arrest after DNA damage Science 282 1998 1497 1501
5. J. Chang, D.H. Kim, S.W. Lee, K.Y. Choi, and Y.C. Sung Transactivation ability of p53 transcriptional activation domain is directly related to the binding affinity to TATA-binding protein J. Biol. Chem. 270 1995 25014 25019
6. C. Chao, S. Saito, J. Kang, C.W. Anderson, E. Appella, and Y. Xu p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage EMBO J. 19 2000 4967 4975
7. A. Damalas, A. Ben-Ze'ev, I. Simcha, M. Shtutman, J.F. Leal, J. Zhurinsky, B. Geiger, and M. Oren Excess beta-catenin promotes accumulation of transcriptionally active p53 EMBO J. 18 1999 3054 3063
8. A. Damalas, S. Kahan, M. Shtutman, A. Ben-Ze'ev, and M. Oren Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation EMBO J. 20 2001 4912 4922
9. Y. Dong, S.L. Chi, A.D. Borowsky, Y. Fan, and R.H. Weiss Cytosolic p21Waf1/Cip1 increases cell cycle transit in vascular smooth muscle cells Cell. Signal. 16 2004 263 269
10. N. Dumaz, and D.W. Meek Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 EMBO J. 18 1999 7002 7010
11. J. Dupont, M. Karas, and D. LeRoith The cyclin-dependent kinase inhibitor p21CIP/WAF is a positive regulator of insulin-like growth factor I-induced cell proliferation in MCF-7 human breast cancer cells J. Biol. Chem. 278 2003 37256 37264
12. W.S. El-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
13. J.M. Espinosa, and B.M. Emerson Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment Mol. Cell 8 2001 57 69
14. J.M. Espinosa, R.E. Verdun, and B.M. Emerson p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage Mol. Cell 12 2003 1015 1027
15. G. Farmer, J. Colgan, Y. Nakatani, J.L. Manley, and C. Prives Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo Mol. Cell. Biol. 16 1996 4295 4304
16. E.R. Flores, K.Y. Tsai, D. Crowley, S. Sengupta, A. Yang, F. McKeon, and T. Jacks p63 and p73 are required for p53-dependent apoptosis in response to DNA damage Nature 416 2002 560 564
17. S. Gendler, J. Taylor-Papadimitriou, T. Duhig, J. Rothbard, and J.A. Burchell A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats J. Biol. Chem. 263 1988 12820 12823
18. N. Horikoshi, A. Usheva, J. Chen, A.J. Levine, R. Weinmann, and T. Shenk Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression Mol. Cell. Biol. 15 1995 227 234
19. J.K. Hsieh, D. Yap, D.J. O'Connor, V. Fogal, L. Fallis, F. Chan, S. Zhong, and X. Lu Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage Mol. Cell. Biol. 22 2002 78 93
20. L. Huang, J. Ren, D. Chen, Y. Li, S. Kharbanda, and D. Kufe MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation Cancer Biol. Ther. 2 2003 702 706
21. M.T. Jack, R.A. Woo, A. Hirao, A. Cheung, T.W. Mak, and P.W. Lee Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response Proc. Natl. Acad. Sci. USA 99 2002 9825 9829
22. L. Jayaraman, K.G. Murthy, C. Zhu, T. Curran, S. Xanthoudakis, and C. Prives Identification of redox/repair protein Ref-1 as a potent activator of p53 Genes Dev. 11 1997 558 570
23. G.S. Jimenez, M. Nister, J.M. Stommel, M. Beeche, E.A. Barcarse, X.Q. Zhang, S. O'Gorman, and G.M. Wahl A transactivation-deficient mouse model provides insights into Trp53 regulation and function Nat. Genet. 26 2000 37 43
24. M.D. Kaeser, and R.D. Iggo Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo Proc. Natl. Acad. Sci. USA 99 2002 95 100
25. T.R. Kau, J.C. Way, and P.A. Silver Nuclear transport and cancer: From mechanism to intervention Nat. Rev. Cancer 4 2004 106 117
26. S. Kharbanda, R. Ren, P. Pandey, T.D. Shafman, S.M. Feller, R.R. Weichselbaum, and D.W. Kufe Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents Nature 376 1995 785 788
27. D. Kufe, G. Inghirami, M. Abe, D. Hayes, H. Justi-Wheeler, and J. Schlom Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors Hybridoma 3 1984 223 232
28. P.F. Lambert, F. Kashanchi, M.F. Radonovich, R. Shiekhattar, and J.N. Brady Phosphorylation of p53 serine 15 increases interaction with CBP J. Biol. Chem. 273 1998 33048 33053
29. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
30. Y. Li, A. Bharti, D. Chen, J. Gong, and D. Kufe Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin Mol. Cell. Biol. 18 1998 7216 7224
31. Y. Li, H. Kuwahara, J. Ren, G. Wen, and D. Kufe The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3β and β-catenin J. Biol. Chem. 276 2001 6061 6064
32. Y. Li, J. Ren, W.-H. Yu, G. Li, H. Kuwahara, L. Yin, K.L. Carraway, and D. Kufe The EGF receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and β-catenin J. Biol. Chem. 276 2001 35239 35242
33. Y. Li, W. Chen, J. Ren, W. Yu, Q. Li, K. Yoshida, and D. Kufe DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7 Cancer Biol. Ther. 2 2003 187 193
34. Y. Li, D. Liu, D. Chen, S. Kharbanda, and D. Kufe Human DF3/MUC1 carcinoma-associated protein functions as an oncogene Oncogene 22 2003 6107 6110
35. Y. Li, W.-H. Yu, J. Ren, L. Huang, S. Kharbanda, M. Loda, and D. Kufe Heregulin targets γ-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 protein Mol. Cancer Res. 1 2003 765 775
36. M.J. Ligtenberg, L. Kruijshaar, F. Buijs, M. van Meijer, S.V. Litvinov, and J. Hilkens Cell-associated episialin is a complex containing two proteins derived from a common precursor J. Biol. Chem. 267 1992 6171 6177
37. X. Liu, C.W. Miller, P.H. Koeffler, and A.J. Berk The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription Mol. Cell. Biol. 13 1993 3291 3300
38. G. Liu, T. Xia, and X. Chen The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein J. Biol. Chem. 278 2003 17557 17565
39. T.K. MacLachlan, R. Takimoto, and W.S. El-Deiry BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets Mol. Cell. Biol. 22 2002 4280 4292
40. G. Merlo, J. Siddiqui, C. Cropp, D.S. Liscia, R. Lidereau, R. Callahan, and D. Kufe DF3 tumor-associated antigen gene is located in a region on chromosome 1q frequently altered in primary human breast cancer Cancer Res. 49 1989 6966 6971
41. T. Miyashita, and J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
42. S. Mujtaba, Y. He, L. Zeng, S. Yan, O. Plotnikova, R. Sanchez, N.J. Zeleznik-Le, Z. Ronai, and M.M. Zhou Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation Mol. Cell 13 2004 251 263
43. M. Muller, S. Wilder, D. Bannasch, D. Israeli, K. Lehlbach, M. Li-Weber, S.L. Friedman, P.R. Galle, W. Stremmel, M. Oren, and P.H. Krammer p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs J. Exp. Med. 188 1998 2033 2045
44. Y. Nie, H. Li, C. Bula, and X. Liu Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization Mol. Cell. Biol. 20 2000 741 748
45. E. Oda, R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi, and N. Tanaka Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis Science 288 2000 1053 1058
46. K. Oda, H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, H. Nishimori, K. Tamai, T. Tokino, Y. Nakamura, and Y. Taya p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 Cell 102 2000 849 862
47. M. Oren Decision making by p53: Life, death and cancer Cell Death Differ. 10 2003 431 442
48. L. Perey, D.F. Hayes, P. Maimonis, M. Abe, C. O'Hara, and D.W. Kufe Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen Cancer Res. 52 1992 2563 2568
49. J. Ren, R. Datta, H. Shioya, Y. Li, E. Oki, V. Biedermann, A. Bharti, and D. Kufe p73β is regulated by protein kinase Cδ catalytic fragment generated in the apoptotic response to DNA damage J. Biol. Chem. 277 2002 33758 33765
50. J. Ren, Y. Li, and D. Kufe Protein kinase C δ regulates function of the DF3/MUC1 carcinoma antigen in β-catenin signaling J. Biol. Chem. 277 2002 17616 17622
51. J. Ren, N. Agata, D. Chen, Y. Li, W.-H. Yu, L. Huang, D. Raina, W. Chen, S. Kharbanda, and D. Kufe Human MUC1 carcinoma-associated protein confers resistance to genotoxic anti-cancer agents Cancer Cell 5 2004 163 175
52. E. Sadot, B. Geiger, M. Oren, and A. Ben-Ze'ev Down-regulation of beta-catenin by activated p53 Mol. Cell. Biol. 21 2001 6768 6781
53. Y. Samuels-Lev, D.J. O'Connor, D. Bergamaschi, G. Trigiante, J.K. Hsieh, S. Zhong, I. Campargue, L. Naumovski, T. Crook, and X. Lu ASPP proteins specifically stimulate the apoptotic function of p53 Mol. Cell 8 2001 781 794
54. J. Schroeder, M. Thompson, M. Gardner, and S. Gendler Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland J. Biol. Chem. 276 2001 13057 13064
55. J.A. Schroeder, A.A. Masri, M.C. Adriance, J.C. Tessier, K.L. Kotlarczyk, M.C. Thompson, and S.J. Gendler MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation Oncogene 23 2004 5739 5747
56. E. Seto, A. Usheva, G. Zambett, J. Momand, R. Horikoshi, A. Weinmann, J. Levine, and T. Shenk Wild-type p53 binds to the TATA-binding protein and represses transcription Proc. Natl. Acad. Sci. USA 89 1992 12028 12032
57. Y. Shang, X. Hu, J. DiRenzo, M.A. Lazar, and M. Brown Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription Cell 103 2000 843 852
58. N. Shikama, C. Lee, S. France, L. Delavaine, J. Lyon, M. Krstic-Demonacos, and N. La Thangue A novel cofactor for p300 that regulates the p53 response Mol. Cell 4 1999 365 376
59. J. Siddiqui, M. Abe, D. Hayes, E. Shani, E. Yunis, and D. Kufe Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen Proc. Natl. Acad. Sci. USA 85 1988 2320 2323
60. E.A. Spillare, A.I. Robles, X.W. Wang, J.C. Shen, C.E. Yu, G.D. Schellenberg, and C.C. Harris p53-mediated apoptosis is attenuated in Werner syndrome cells Genes Dev. 13 1999 1355 1360
61. S.T. Szak, D. Mays, and J.A. Pietenpol Kinetics of p53 binding to promoter sites in vivo Mol. Cell. Biol. 21 2001 3375 3386
62. P.D. Vermeer, L.A. Einwalter, T.O. Moninger, T. Rokhlina, J.A. Kern, J. Zabner, and M.J. Welsh Segregation of receptor and ligand regulates activation of epithelial growth factor receptor Nature 422 2003 322 326
63. K.H. Vousden, and X. Lu Live or let die: The cell's response to p53 Nat. Rev. Cancer 2 2002 594 604
64. G.M. Wahl, and A.M. Carr The evolution of diverse biological responses to DNA damage: Insights from yeast and p53 Nat. Cell Biol. 3 2001 E277 E286
65. T. Wang, T. Kobayashi, R. Takimoto, A.E. Denes, E.L. Snyder, W.S. el-Deiry, and R.K. Brachmann hADA3 is required for p53 activity EMBO J. 20 2001 6404 6413
66. L.N. Wei, M. Farooqui, and X. Hu Ligand-dependent formation of retinoid receptors, receptor-interacting protein 140 (RIP140), and histone deacetylase complex is mediated by a novel receptor-interacting motif of RIP140 J. Biol. Chem. 276 2001 16107 16112
67. X. Wei, Z.K. Yu, A. Ramalingam, S.R. Grossman, J.H. Yu, D.B. Bloch, and C.G. Maki Physical and functional interactions between PML and MDM2 J. Biol. Chem. 278 2003 29288 29297
68. R.H. Weiss p21Waf1/Cip1 as a therapeutic target in breast and other cancers Cancer Cell 4 2003 425 429
69. Y. Wen, T. Caffrey, M. Wheelock, K. Johnson, and M. Hollingsworth Nuclear association of the cytoplasmic tail of MUC1 and β-catenin J. Biol. Chem. 278 2003 38029 38039
70. G.S. Wu, T.F. Burns, E.R. McDonald 3rd, W. Jiang, R. Meng, I.D. Krantz, G. Kao, D.D. Gan, J.Y. Zhou, and R. Muschel KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene Nat. Genet. 17 1997 141 143
71. M. Yamamoto, A. Bharti, Y. Li, and D. Kufe Interaction of the DF3/MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion J. Biol. Chem. 272 1997 12492 12494
72. L. Yin, and D. Kufe Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress J. Biol. Chem. 278 2003 35458 35464
73. L. Yin, L. Huang, and D. Kufe MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress J. Biol. Chem. 279 2004 45721 45727
74. J. Yu, L. Zhang, P.M. Hwang, K.W. Kinzler, and B. Vogelstein PUMA induces the rapid apoptosis of colorectal cancer cells Mol. Cell 7 2001 673 682
75. Z. Yuan, Y. Huang, M. Fan, C. Sawers, S. Kharbanda, and D. Kufe Genotoxic drugs induce interaction of the c-Abl tyrosine kinase and the tumor suppressor protein p53 J. Biol. Chem. 271 1996 26457 26460
76. Z. Yuan, Y. Huang, T. Ishiko, S. Kharbanda, R. Weichselbaum, and D. Kufe Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase Proc. Natl. Acad. Sci. USA 94 1997 1437 1440
77. C. Zhang, M.M. Kavurma, A. Lai, and L.M. Khachigian Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1: ETS-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in the p21WAF/Cip1 promoter J. Biol. Chem. 278 2003 27903 27909